If you are a healthcare professional outside of the U.S., please visit Aloxi.net.

Take the CINV assessment

Go to Quiz
Do you have CINV? Take this assessment to see if you should be concerned about your symptoms.

Record your CINV symptoms

Print the Tracker
Download our symptom tracker and share your results with your physician.

Discover tips to manage CINV

Learn helpful tips
Following these diet and lifestyle tips may help manage the symptoms
of CINV.

Download ALOXI information

Learn helpful tips
Get answers to your ALOXI questions with our brochure.

Likelihood of experiencing CINV

Your doctor and oncology team will create a treatment plan specifically for you. As part of this plan, you may be administered chemotherapy to help you fight your cancer. Certain types of chemotherapy can cause people to feel sick. Feeling sick often includes nausea and vomiting.

If no preventive measures are taken before beginning chemotherapy, around 70%-80% of patients may experience nausea or vomiting from chemo.

About 7 or 8 out of every 10 people receiving chemo may experience CINV without preventive measures.

Patients

Emetogenic Potential

Not all chemotherapy causes the same level of CINV. Some types of chemotherapy have a greater risk of making you sick. This is called emetogenic (eh-meh-tow-JEH-nik) potential.

Chemotherapy that is highly emetogenic, or that has a high emetic risk, is very likely to cause nausea and vomiting, (90% or more of the time) if no preventive measures are taken.

Chemotherapy that is likely to cause nausea and vomiting is called moderately emetogenic or is said to have moderate emetic risk. Chemotherapy that is moderately emetogenic, or that has a moderate emetic risk, is likely to cause nausea and vomiting 30-90% of the time if no preventive measures are taken.

Your healthcare professional can tell you if you will receive highly or moderately emetogenic chemotherapy.

To see some additional risk factors for developing CINV, take the CINV risk factor assessment.

Indication

ALOXI injection is used in adults to help prevent nausea and vomiting on the day of chemotherapy that is highly likely to cause nausea and vomiting, and up to 5 days following chemotherapy that is moderately likely to cause nausea and vomiting.

Important Safety Information

  • Tell your healthcare professional if you are taking other medications or if you are pregnant or breastfeeding
  • The most common side effects of ALOXI® for the prevention of CINV are headache and constipation

Please read the Full Product Information and discuss it with your doctor or health care professional.

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit http://www.FDA.gov/medwatch or call 1-800-FDA-1088.